ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae (SAVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01471041
Recruitment Status : Completed
First Posted : November 11, 2011
Results First Posted : June 3, 2016
Last Update Posted : June 3, 2016
Sponsor:
Information provided by (Responsible Party):
Vital Access Corp.

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The SAVE Study will evaluate the safety and efficacy of the Venous Window Needle Guide in achieving access of a deep, un-cannulatable arteriovenous fistula to complete hemodialysis as prescribed.

Condition or disease Intervention/treatment Phase
End Stage Renal Disease AV Fistula Kidney Failure Device: Venous Window Needle Guide Phase 2 Phase 3

Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 54 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
Study Start Date : December 2011
Actual Primary Completion Date : March 2013
Actual Study Completion Date : June 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fistulas
U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Venous Window Needle Guide
Venous Window Needle Guide will be implanted onto deep, un-cannulatable arteriovenous fistula
 Device: Venous Window Needle Guide
Subcutaneous, extravascular needle guide made of medical-grade titanium
Other Name: VWNG


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Use of Venous Window Needle Guide to Obtain Arteriovenous Access for Hemodialysis [ Time Frame: 3 months ]
    Successful cannulation of arteriovenous fistula through the VWNG device and successful hemodialysis achieved within 3 months from index procedure.


Secondary Outcome Measures :
  1. Arteriovenous Fistula Cannulation Complications While Using the Venous Window Needle Guide [ Time Frame: 6 months ]
    Frequency of complications occuring when cannulating the arteriovenous fistula through the Venous Window Needle Guide


Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Deep, uncannulatable, upper extremity arteriovenous fistula
  • Minimum arteriovenous fistula flow 400 ml/min
  • One year life expectancy

Exclusion Criteria:

  • Non-transposed basilic or brachial vein arteriovenous fistula
  • History of peripheral vascular disease
  • History of cardiovascular disease
  • History of cerebral vascular disease
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01471041


Locations
United States, California
Ladenheim Dialysis Access Centers
Fresno, California, United States, 93710
United States, Oklahoma
University of Oklahoma - Tulsa
Tulsa, Oklahoma, United States, 74104
Sponsors and Collaborators
Vital Access Corp.
Investigators
Study Director: Mark Crawford, BA Vital Access
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Vital Access Corp.
ClinicalTrials.gov Identifier: NCT01471041     History of Changes
Other Study ID Numbers: VA 024
First Posted: November 11, 2011    Key Record Dates
Results First Posted: June 3, 2016
Last Update Posted: June 3, 2016
Last Verified: April 2016

Keywords provided by Vital Access Corp.:
End Stage Renal Disease
Hemodialysis
AV fistula
Kidney failure

Additional relevant MeSH terms:
Arteriovenous Fistula
Kidney Diseases
Kidney Failure, Chronic
Fistula
Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic
Pathological Conditions, Anatomical
 Arteriovenous Malformations
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Fistula
Vascular Diseases
Congenital Abnormalities